The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEMINI: An open-label, single-arm, phase II trial of intraoperative gemcitabine intravesical instillation in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
 
Vignesh T. Packiam
Honoraria - CG Oncology
 
Bradley C. Leibovich
No Relationships to Disclose
 
R. Houston Thompson
Patents, Royalties, Other Intellectual Property - Patent for B7-H1 and survivin as prognostic markers in renal cell carcinoma.
 
Aaron M. Potretzke
No Relationships to Disclose
 
George K. Chow
No Relationships to Disclose
 
Matthew K. Tollefson
No Relationships to Disclose
 
Phillip J. Schulte
No Relationships to Disclose
 
Mark Tyson
No Relationships to Disclose
 
Timothy D. Lyon
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - Ferring; Sanofi